Sanofi India Ltd
SANOFISanofi India Ltd
SANOFIPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
33.15 | 19.69 | 1.92% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.80 | 5.98 | 0.57% |
Forecast & Ratings
Detailed Forecastfrom 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2,328.30 | 2,433.20 | 2,540.60 | 2,860.50 | 3,164.70 | 2,991.70 | 3,520.20 | 2,973.60 | 2,934.20 | 2,934.20 | ||||||||||
Raw Materials | 975.20 | 1,100.20 | 906.40 | 1,206.40 | 1,345.10 | 1,196.10 | 1,263.70 | 1,200.70 | 1,493.40 | 2,047.40 | ||||||||||
Power & Fuel Cost | 31.40 | 31.70 | 33.40 | 40.00 | 42.30 | 23.60 | 13.90 | 14.30 | 14.60 | |||||||||||
Employee Cost | 333.30 | 355.30 | 368.50 | 406.80 | 449.70 | 460.80 | 433.90 | 405.90 | 370.60 | |||||||||||
Selling & Administrative Expenses | 355.90 | 368.00 | 390.40 | 425.50 | 433.80 | 306.80 | 306.90 | 315.70 | 332.90 | |||||||||||
Operating & Other expenses | 38.20 | -23.50 | 224.00 | 68.60 | 193.70 | 243.20 | 175.70 | 129.10 | -164.10 | |||||||||||
EBITDA | 594.30 | 601.50 | 617.90 | 713.20 | 700.10 | 761.20 | 1,326.10 | 907.90 | 886.80 | 886.80 | ||||||||||
Depreciation/Amortization | 113.00 | 118.80 | 102.20 | 102.70 | 99.90 | 82.20 | 66.70 | 41.90 | 39.60 | 39.60 | ||||||||||
PBIT | 481.30 | 482.70 | 515.70 | 610.50 | 600.20 | 679.00 | 1,259.40 | 866.00 | 847.20 | 847.20 | ||||||||||
Interest & Other Items | 0.40 | 2.30 | 1.10 | 0.70 | 0.30 | 1.80 | 1.80 | 1.70 | 1.70 | 1.70 | ||||||||||
PBT | 480.90 | 480.40 | 514.60 | 609.80 | 599.90 | 677.20 | 1,257.60 | 864.30 | 845.50 | 845.50 | ||||||||||
Taxes & Other Items | 159.40 | 176.20 | 188.60 | 229.20 | 185.70 | 199.60 | 313.20 | 243.70 | 242.60 | 242.60 | ||||||||||
Net Income | 321.50 | 304.20 | 326.00 | 380.60 | 414.20 | 477.60 | 944.40 | 620.60 | 602.90 | 602.90 | ||||||||||
EPS | 139.60 | 132.09 | 141.55 | 165.26 | 179.85 | 207.38 | 410.06 | 269.47 | 261.78 | 261.78 | ||||||||||
DPS | 65.00 | 68.00 | 71.00 | 84.00 | 349.00 | 365.00 | 490.00 | 570.00 | 167.00 | 377.00 | ||||||||||
Payout ratio | 0.47 | 0.51 | 0.50 | 0.51 | 1.94 | 1.76 | 1.19 | 2.12 | 0.64 | 1.44 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sanofi India Ltd | 33.15 | 19.69 | 1.92% |
Sun Pharmaceutical Industries Ltd | 43.01 | 6.14 | 0.76% |
Cipla Ltd | 40.92 | 4.83 | 0.60% |
Dr Reddy's Laboratories Ltd | 23.23 | 4.50 | 0.64% |
Price Comparison
Compare SANOFI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Sanofi India Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Aditya Birla Sun Life Frontline Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1208% | Percentage of the fund’s portfolio invested in the stock 0.83% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/91 (+1) |
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.9582% | Percentage of the fund’s portfolio invested in the stock 2.69% | Change in the portfolio weight of the stock over the last 3 months -0.26% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 17/36 (0) |
Nippon India GROWTH FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.9207% | Percentage of the fund’s portfolio invested in the stock 0.74% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/105 (-4) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Trend In Dividends
SANOFI has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Current dividend yield is 1.92%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.24 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateMay 3, 2024
Dividend/Share
₹117.00
Ex DateEx Date
May 3, 2024
Cash Dividend
Ex DateEx DateMar 7, 2024
Dividend/Share
₹50.00
Ex DateEx Date
Mar 7, 2024
Cash Dividend
Ex DateEx DateApr 28, 2023
Dividend/Share
₹183.00
Ex DateEx Date
Apr 28, 2023
Cash Dividend
Ex DateEx DateApr 28, 2023
Dividend/Share
₹194.00
Ex DateEx Date
Apr 28, 2023
Cash Dividend
Ex DateEx DateAug 5, 2022
Dividend/Share
₹193.00
Ex DateEx Date
Aug 5, 2022
News & Opinions
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
1 month ago•Moneycontrol
Stocks To Watch: CDSL, Wipro, Sanofi India, Cipla, Titan, Piramal Enterprises
1 month ago•Bloomberg Quint
Sanofi to buy Inhibrx for $2.2 billion in rare disease push
3 months ago•Moneycontrol
Lupin To Acquire Established Products In Europe, Canada From Sanofi For Rs 91 Crore
4 months ago•Bloomberg Quint
Amazon Pharmacy automates discounts to help insulin patients get pledged prices
8 months ago•Economic Times
Sanofi India Q2 Results Review - Margins Remain Resilient Despite NLEM Impact: Nirmal Bang
8 months ago•Bloomberg Quint
Sanofi India Standalone June 2023 Net Sales at Rs 706.10 crore, up 0.97% Y-o-Y
8 months ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 0.51%, vs industry avg of 8.36%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.41% to 0.9%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 9.64%, vs industry avg of 9.82%